ROIV vs SPY
Roivant Sciences Ltd (ROIV) versus SPDR S&P 500 ETF Trust (SPY) — a side-by-side from cached financials, not a winner call.
Roivant Sciences Ltd (ROIV) is a biotechnology company listed on US.
SPDR S&P 500 ETF Trust (SPY) common stock listed on US.
Latest reported ROIV revenue for 2026-03-31 was $8.3M. Net income was -$299.8M. Revenue was down 71.6% from 2025-03-31 to 2026-03-31. ROIV currently screens at market cap $7.47B.
SPY does not have a complete income-statement cache yet.
ROIV currently screens at market cap $7.47B. SPY currently screens at market cap $0.
Not investment advice. Open the ROIV and SPY stock pages for the full models.
Not investment advice.